Electronic Device Recall Program Launch Scheduled For Mid-Year
This article was originally published in The Gray Sheet
Executive Summary
FDA's Office of Regulatory Affairs (ORA) expects to convert the agency's recall processing operation to an electronic media format within six months. The move represents the first by the device center as part of a comprehensive recall reengineering effort.
You may also be interested in...
FDA district classification of Class II/III recalls being tested in reengineering pilot.
CLASS II/III RECALL CLASSIFICATION AT DISTRICT LEVEL will be tested by FDA's Boston District Office under a recall process reengineering pilot scheduled to commence in June. The program is intended to help the agency make more efficient use of resources by shifting classification responsibility for Class II and Class III recalls from the Center for Devices and Radiological Health to field office recall coordinators, the staffers who currently make recall classification recommendations to CDRH. CDRH will retain responsibility for processing Class I recalls.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.